News | February 09, 2024
Spriya Lifescience Q3 FY24 PAT jumps 213% at Rs. 29.79 Cr
EBITDA for Q3 FY24 almost tripled to reach Rs. 41.49 crore
EBITDA for Q3 FY24 almost tripled to reach Rs. 41.49 crore
Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry
An accomplished R&D leader and champion of the application of AI to drug discovery
The bold, dynamic, and new logo unveiled in this process captures the essence of the 'Better Together' theme
Microdosing has emerged as a key trend in the pharmaceutical and nutritional markets
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
The Institute is catering the health needs of the surrounding population with ever-increasing OPD every year along with special OPDs like mother & Child OPD, and LSD clinic
Launch innovative vitamin sublingual sprays
Arco Lab now holds a 50% stake in Neviton
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
Subscribe To Our Newsletter & Stay Updated
